申请人:Biolipox AB
公开号:US08097623B2
公开(公告)日:2012-01-17
There is provided compounds of formula (I), wherein X1, Q, T, Y, R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
提供化合物(I)的公式,其中X1、Q、T、Y、R1、R2、R3、R4和R5的含义见说明,以及其药学上可接受的盐。这些化合物在治疗需要和/或期望抑制MAPEG家族成员活性的疾病中非常有用,特别是在治疗炎症方面。